ConductScience.org, home

Paper9506239

Combination diuretic therapy in severe congestive heart failure.

Dormans TP and 3 others. Drugs, 1998. Cited by 36 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Combination diuretic therapy in severe congestive heart failure. Papers, record 9506239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9506239

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination diuretic therapy in severe congestive heart failure.
PubMed
Journal
Drugs
PubMed
Year
1998
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.08
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dormans TPT P
2Gerlag PGP G
3Russel FGF G
4Smits PP

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DiureticsMajor topic
Heart FailureMajor topic
KidneyMajor topic
Drug Resistance
Drug Synergism
Drug Therapy, Combination
Humans

Source PubMed

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12,811,065Mechanism of impaired natriuretic response to furosemide during prolonged therapy.Kidney Int1989https://conductscience.org/library/papers/2811065PubMed
24,056,058Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion.J Clin Invest1985https://conductscience.org/library/papers/4056058PubMed
38,422,000Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.Am J Cardiol1993https://conductscience.org/library/papers/8422000PubMed
42,014,951The physiologic basis of diuretic synergism: its role in treating diuretic resistance.Ann Intern Med1991https://conductscience.org/library/papers/2014951PubMed
58,800,113Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.J Am Coll Cardiol1996https://conductscience.org/library/papers/8800113PubMed
69,152,644The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.Eur Heart J1997https://conductscience.org/library/papers/9152644PubMed
71,858,894Adaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion.Am J Physiol1991https://conductscience.org/library/papers/1858894PubMed
88,944,582Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.Heart1996https://conductscience.org/library/papers/8944582PubMed
98,151,264Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.J Intern Med1994https://conductscience.org/library/papers/8151264PubMed
109,284,857Role of duration of diuretic effect in preventing sodium retention.Clin Pharmacol Ther1997https://conductscience.org/library/papers/9284857PubMed
113,631,283Thiazide-sensitive sodium chloride cotransport in early distal tubule.Am J Physiol1987https://conductscience.org/library/papers/3631283PubMed
122,188,836Sympathetic activation in congestive heart failure.Eur Heart J1990https://conductscience.org/library/papers/2188836PubMed
131,967,337Metolazone in treatment of severe refractory congestive cardiac failure.Lancet1990https://conductscience.org/library/papers/1967337PubMed
148,689,815Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.Clin Pharmacol Ther1996https://conductscience.org/library/papers/8689815PubMed
158,583,780Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.J Cardiovasc Pharmacol1995https://conductscience.org/library/papers/8583780PubMed
169,125,675Sequential nephron blockade breaks resistance to diuretics in edematous states.J Cardiovasc Pharmacol1997https://conductscience.org/library/papers/9125675PubMed
171,352,022Pathophysiology of chronic heart failure.Lancet1992https://conductscience.org/library/papers/1352022PubMed
181,970,014Thiazides with loop diuretics for severe congestive heart failure.Lancet1990https://conductscience.org/library/papers/1970014PubMed
196,503,136Bumetanide and furosemide in heart failure.Kidney Int1984https://conductscience.org/library/papers/6503136PubMed
204,950,425Combination diuretic drug therapy.Cardiovasc Clin1971https://conductscience.org/library/papers/4950425PubMed

See all 58 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
38,541,899The Changing Role of Loop Diuretics in Heart Failure Management across the Last Century.J Clin Med2024https://conductscience.org/library/papers/38541899PubMed
34,852,633Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics.Hypertension2022https://conductscience.org/library/papers/34852633PubMed
33,392,884Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review.Int Urol Nephrol2021https://conductscience.org/library/papers/33392884PubMed
26,521,190Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.Adv Ther2015https://conductscience.org/library/papers/26521190PubMed
24,357,134Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence.Drugs Aging2014https://conductscience.org/library/papers/24357134PubMed
24,223,323Acute Heart Failure Treatment.Curr Emerg Hosp Med Rep2013https://conductscience.org/library/papers/24223323PubMed
23,319,101Causes and treatment of oedema in patients with heart failure.Nat Rev Cardiol2013https://conductscience.org/library/papers/23319101PubMed
17,245,481Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.Can J Cardiol2007https://conductscience.org/library/papers/17245481PubMed
15,809,817The cardiorenal syndrome: lessons from the ADHERE database and treatment options.Heart Fail Rev2004https://conductscience.org/library/papers/15809817PubMed
12,038,877Severe heart failure in the elderly: potential benefits of high-dose and continuous infusion diuretics.Drugs Aging2002https://conductscience.org/library/papers/12038877PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9506239

GET https://conductscience.org/api/papers/v1/9506239/references?page=2